Jenburkt Pharmaceuticals Ltd. - Research Center
524731 JENBURPH Group (X) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
67.46 |
66.98 |
61.29 |
62.69 |
47.92 |
Operating profit |
16.07 |
15.89 |
11.63 |
15.63 |
7.80 |
Interest |
0.14 |
0.18 |
0.22 |
0.21 |
0.24 |
Gross profit |
18.06 |
18.11 |
13.97 |
17.80 |
9.56 |
EPS (Rs) |
28.76 |
27.93 |
21.08 |
27.50 |
14.56 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
2.13 |
2.40 |
2.56 |
2.39 |
2.00 |
Stock adjustment |
-1.31 |
-1.13 |
-2.54 |
0.25 |
-1.35 |
Raw material |
3.72 |
5.57 |
6.31 |
5.43 |
2.92 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
20.55 |
19.24 |
18.73 |
17.76 |
16.02 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
28.42 |
27.41 |
27.17 |
23.61 |
22.53 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
1.09 |
1.08 |
1.01 |
0.89 |
1.00 |
Taxation |
4.28 |
4.21 |
3.28 |
4.29 |
1.88 |
Net profit / loss |
12.69 |
12.82 |
9.68 |
12.62 |
6.68 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
4.41 |
4.59 |
4.59 |
4.59 |
4.59 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
23.82 |
23.72 |
18.97 |
24.93 |
16.28 |
GPM (%) |
25.95 |
26.10 |
21.87 |
27.36 |
19.16 |
NPM (%) |
18.23 |
18.47 |
15.15 |
19.40 |
13.38 |